CaNO Measurement Module

Hospital-based exhaled nitric oxide (FeNO) detection system designed for patients with complications and critical illnesses. Enables multi-molecular, multi-airway exhaled gas combined testing to assess airway inflammation and dysbiosis markers for respiratory system disease precision medicine.

A multi-molecular, multi-site, multi-parameter breath analysis system for detecting inflammation and related conditions. The CA series includes multiple configurations (CA3478, CA3138, CA4458) that measure various exhaled gases including NO, CO, H2S, CH4, CO2, and O2 in different combinations. It supports online and offline sampling modes with quality control features, and is designed for respiratory, pediatric, ENT, surgical, radiology, and physical examination departments to diagnose conditions such as asthma, COPD, interstitial lung disease, lung cancer, chronic cough, allergic rhinitis, sinusitis, and perioperative pulmonary complications.

Diagnostic system detecting nitric oxide in exhaled breath to evaluate airway inflammation and diagnose primary ciliary dyskinesia. Provides non-invasive assessment of respiratory tract conditions.

A breath analysis device for multi-molecular, multi-site, multi-parameter testing of respiratory and digestive conditions with complications. The CA series includes inflammatory phenotyping breath testing with NO baseline plus CO and H2S optional configurations, supporting online standard, offline, and tidal breath modes. It features breath quality control with standard gas and self-calibration, and is applicable to respiratory, pediatric, otolaryngology, surgery, radiology, and health screening departments for conditions including asthma, COPD, interstitial lung disease, lung cancer, chronic cough, allergic rhinitis, sinusitis, nasal polyps, radiation pneumonitis, and perioperative pulmonary complications.

Portable breath analyzer for measuring fractional exhaled nitric oxide (FeNO) levels, used in clinical assessment of airway inflammation and asthma management. The device provides rapid, non-invasive diagnostic testing suitable for point-of-care and home-based monitoring applications.

A medical device used to measure nitric oxide and carbon dioxide levels in human exhaled breath. It supports both oral and nasal breathing modes with a measurement range of 1ppb to 3500ppb, enabling detection of airway inflammation and respiratory conditions.

Primary care-based exhaled nitric oxide (FeNO) detection system for guiding drug selection assessment and evaluating therapeutic efficacy. Enables combined or self-testing of exhaled nitrogen oxide to assess airway inflammation and dysbiosis markers in grassroots medical settings.

The NObreath® FeNO device measures fractional exhaled nitric oxide (FeNO) to assess airway inflammation and aid in asthma diagnosis and management. This non-invasive breath test conforms to BTS/NICE/SIGN, ATS, and ERS guidelines and is suitable for both adult and pediatric patients. The device includes ambient NO monitoring capability for environmental assessment.

Home-use exhaled nitric oxide (FeNO) self-testing device for patients to monitor treatment compliance and acute exacerbations. Designed for patients to perform self-testing of exhaled nitrogen oxide to track airway inflammation status at home.

System for detecting nitric oxide and carbon dioxide levels in human breath samples. Supports both oral and nasal breathing modes with measurement range of 1ppb to 3500ppb. Used for non-invasive monitoring of respiratory and circulatory parameters.

A breath analysis system available in three configurations: CA3478 (NO+H2+CO2), CA3138 (NO+H2S+CO2), and CA4458 (NO+H2S+H2+CH4+CO2+O2) for combined assessment of inflammation and intestinal microbiota. The device is applicable in digestive and oral clinics, pediatrics, physical examinations, and allergy departments for diagnosis of conditions including irritable bowel syndrome, inflammatory bowel disease, colorectal cancer, Helicobacter pylori infection, functional dyspepsia, liver disease, halitosis, and allergic rhinitis/asthma.

Hospital-based exhaled nitric oxide (FeNO) detection system designed for patients with complications and critical illnesses. Enables multi-molecular, multi-airway exhaled gas combined testing to assess airway inflammation and dysbiosis markers for respiratory system disease precision medicine.